List of Tables
Table 1. Global Peptide-Drug Conjugates Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell-penetrating Peptides (CPPs)
Table 3. Key Players of Cell-targeting Peptides (CTPs)
Table 4. Global Peptide-Drug Conjugates Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide-Drug Conjugates Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide-Drug Conjugates Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide-Drug Conjugates Market Share by Region (2020-2025)
Table 8. Global Peptide-Drug Conjugates Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide-Drug Conjugates Market Share by Region (2026-2031)
Table 10. Peptide-Drug Conjugates Market Trends
Table 11. Peptide-Drug Conjugates Market Drivers
Table 12. Peptide-Drug Conjugates Market Challenges
Table 13. Peptide-Drug Conjugates Market Restraints
Table 14. Global Peptide-Drug Conjugates Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide-Drug Conjugates Market Share by Players (2020-2025)
Table 16. Global Top Peptide-Drug Conjugates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates as of 2024)
Table 17. Ranking of Global Top Peptide-Drug Conjugates Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide-Drug Conjugates Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide-Drug Conjugates, Headquarters and Area Served
Table 20. Global Key Players of Peptide-Drug Conjugates, Product and Application
Table 21. Global Key Players of Peptide-Drug Conjugates, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide-Drug Conjugates Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide-Drug Conjugates Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide-Drug Conjugates Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide-Drug Conjugates Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide-Drug Conjugates Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide-Drug Conjugates Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide-Drug Conjugates Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide-Drug Conjugates Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide-Drug Conjugates Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide-Drug Conjugates Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide-Drug Conjugates Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide-Drug Conjugates Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide-Drug Conjugates Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide-Drug Conjugates Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide-Drug Conjugates Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide-Drug Conjugates Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide-Drug Conjugates Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide-Drug Conjugates Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide-Drug Conjugates Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide-Drug Conjugates Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide-Drug Conjugates Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide-Drug Conjugates Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide-Drug Conjugates Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZeneca Company Details
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Peptide-Drug Conjugates Product
Table 49. AstraZeneca Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Bicycle Therapeutics Company Details
Table 52. Bicycle Therapeutics Business Overview
Table 53. Bicycle Therapeutics Peptide-Drug Conjugates Product
Table 54. Bicycle Therapeutics Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 55. Bicycle Therapeutics Recent Development
Table 56. Cybrexa Therapeutics Company Details
Table 57. Cybrexa Therapeutics Business Overview
Table 58. Cybrexa Therapeutics Peptide-Drug Conjugates Product
Table 59. Cybrexa Therapeutics Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 60. Cybrexa Therapeutics Recent Development
Table 61. Esperance Pharmaceuticals Company Details
Table 62. Esperance Pharmaceuticals Business Overview
Table 63. Esperance Pharmaceuticals Peptide-Drug Conjugates Product
Table 64. Esperance Pharmaceuticals Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 65. Esperance Pharmaceuticals Recent Development
Table 66. Oncopeptides Company Details
Table 67. Oncopeptides Business Overview
Table 68. Oncopeptides Peptide-Drug Conjugates Product
Table 69. Oncopeptides Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 70. Oncopeptides Recent Development
Table 71. Pepgen Corporation Company Details
Table 72. Pepgen Corporation Business Overview
Table 73. Pepgen Corporation Peptide-Drug Conjugates Product
Table 74. Pepgen Corporation Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 75. Pepgen Corporation Recent Development
Table 76. Soricimed Biopharma Company Details
Table 77. Soricimed Biopharma Business Overview
Table 78. Soricimed Biopharma Peptide-Drug Conjugates Product
Table 79. Soricimed Biopharma Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 80. Soricimed Biopharma Recent Development
Table 81. Theratechnologies Company Details
Table 82. Theratechnologies Business Overview
Table 83. Theratechnologies Peptide-Drug Conjugates Product
Table 84. Theratechnologies Revenue in Peptide-Drug Conjugates Business (2020-2025) & (US$ Million)
Table 85. Theratechnologies Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Peptide-Drug Conjugates Picture
Figure 2. Global Peptide-Drug Conjugates Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide-Drug Conjugates Market Share by Type: 2024 VS 2031
Figure 4. Cell-penetrating Peptides (CPPs) Features
Figure 5. Cell-targeting Peptides (CTPs) Features
Figure 6. Global Peptide-Drug Conjugates Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide-Drug Conjugates Market Share by Application: 2024 VS 2031
Figure 8. Carcinoma Case Studies
Figure 9. Sarcoma Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Leukemia Case Studies
Figure 13. Peptide-Drug Conjugates Report Years Considered
Figure 14. Global Peptide-Drug Conjugates Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Peptide-Drug Conjugates Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Peptide-Drug Conjugates Market Share by Region: 2024 VS 2031
Figure 17. Global Peptide-Drug Conjugates Market Share by Players in 2024
Figure 18. Global Top Peptide-Drug Conjugates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Peptide-Drug Conjugates Revenue in 2024
Figure 20. North America Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Peptide-Drug Conjugates Market Share by Country (2020-2031)
Figure 22. United States Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Peptide-Drug Conjugates Market Share by Country (2020-2031)
Figure 26. Germany Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Peptide-Drug Conjugates Market Share by Region (2020-2031)
Figure 34. China Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Peptide-Drug Conjugates Market Share by Country (2020-2031)
Figure 42. Mexico Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Peptide-Drug Conjugates Market Share by Country (2020-2031)
Figure 46. Turkey Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Peptide-Drug Conjugates Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 50. Bicycle Therapeutics Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 51. Cybrexa Therapeutics Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 52. Esperance Pharmaceuticals Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 53. Oncopeptides Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 54. Pepgen Corporation Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 55. Soricimed Biopharma Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 56. Theratechnologies Revenue Growth Rate in Peptide-Drug Conjugates Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
